Invesco Pharmaceuticals ETF
PJP
PJP
96 hedge funds and large institutions have $110M invested in Invesco Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $134M → $110M (-$24.2M)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
64% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 42
Holders
96
Holding in Top 10
1
Calls
$621K
Puts
$495K
Top Buyers
| 1 | +$1.64M | |
| 2 | +$1.57M | |
| 3 | +$846K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$688K |
| 5 |
PAM
Peak Asset Management
Louisville,
Colorado
|
+$443K |
Top Sellers
| 1 | -$9.94M | |
| 2 | -$2.94M | |
| 3 | -$2.63M | |
| 4 |
M&T Bank
Buffalo,
New York
|
-$2.33M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$2.06M |